CDK Inhibitors approved by PBAC 20 April 2018

CDK Inhibitors approved by the Pharmaceutical Benefits Advisory Committee (PBAC) but cost is still an issue.   See the link below for further information https://www.bcna.org.au/news/2018/04/cdk-i...